Monte Rosa Therapeutics I... (GLUE)
NASDAQ: GLUE
· Real-Time Price · USD
4.59
0.24 (5.52%)
At close: Aug 15, 2025, 3:59 PM
4.67
1.63%
After-hours: Aug 15, 2025, 05:25 PM EDT
Monte Rosa Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -7.54 | 2.03 | 7.93 | -4.55 | -2.31 | -3.36 | -2.42 | -1.71 | -2.41 | -3.22 | -3.2 | -3.63 | -4.39 | -6.93 | -10.02 | -12.91 | -1.56 | -18.35 |
PEG Ratio | 0.06 | 0.01 | -0.05 | 0.14 | 0.12 | 0.39 | 0.14 | 1.21 | -0.13 | -1.9 | -0.6 | -2 | -0.56 | n/a | -0.54 | 0.15 | -0.00 | 0.27 |
PS Ratio | 15.98 | 4.49 | 7.03 | 47.16 | 59.78 | 403.68 | 36.75 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.38 | 1.39 | 1.91 | 2.12 | 1.25 | 2.82 | 1.79 | 1.29 | 1.58 | 1.58 | 1.37 | 1.31 | 1.49 | 2.00 | 2.70 | 2.77 | 0.32 | -14.86 |
P/FCF Ratio | -10.18 | -8.1 | 3.31 | -20.32 | -9.42 | -10.86 | 11.51 | -9.05 | -10.64 | -11.8 | -11.91 | -17.35 | -19.58 | -22.46 | -54.5 | -52.41 | -7.07 | -56.2 |
P/OCF Ratio | -10.68 | -8.38 | 3.31 | -20.7 | -10.11 | -11.25 | 10.85 | -9.66 | -13.37 | -16.42 | -15.53 | -18.53 | -22.01 | -23.84 | -66.26 | -57.58 | -8.47 | -65.22 |
OCF/S Ratio | -1.5 | -0.54 | 2.13 | -2.28 | -5.91 | -35.87 | 3.39 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.15 | 0.15 | 0.19 | 0.21 | 0.20 | 0.30 | 0.26 | 0.25 | 0.22 | 0.19 | 0.17 | 0.16 | 0.16 | 0.02 | n/a | n/a | n/a | -3.81 |
Quick Ratio | 7.16 | 5.61 | 2.40 | 6.03 | 6.56 | 4.82 | 5.07 | 8.09 | 10.90 | 11.68 | 10.75 | 13.55 | 20.11 | 25.65 | 20.96 | 29.08 | 33.20 | 18.89 |
Current Ratio | 7.16 | 5.61 | 2.40 | 6.03 | 6.56 | 4.82 | 5.07 | 8.09 | 10.90 | 11.73 | 10.79 | 13.55 | 20.11 | 25.65 | 20.96 | 29.08 | 33.20 | 18.89 |
Asset Turnover | 0.06 | 0.22 | 0.14 | 0.03 | 0.01 | 0.00 | 0.03 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.05 | 0.17 | 0.06 | -0.12 | -0.13 | -0.21 | -0.19 | -0.19 | -0.16 | -0.12 | -0.11 | -0.09 | -0.09 | -0.07 | -0.07 | -0.05 | -0.05 | 0.20 |
Return on Assets | -0.03 | 0.12 | 0.03 | -0.08 | -0.09 | -0.12 | -0.11 | -0.14 | -0.13 | -0.1 | -0.08 | -0.07 | -0.07 | -0.07 | -0.06 | -0.05 | -0.05 | -0.07 |
Return on Invested Capital | -0.05 | 0.13 | 0.04 | -0.1 | -0.11 | -0.15 | -0.13 | -0.16 | -0.14 | -0.11 | -0.09 | -0.08 | -0.07 | -0.07 | -0.07 | -0.05 | -0.05 | -0.07 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.91 | 1.00 | 0.93 | 1.00 | 0.56 | -0.78 | -0.21 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -0.53 | 0.55 | 0.22 | -2.59 | -6.46 | -30.05 | -3.8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -0.48 | 0.56 | 0.26 | -2.58 | -6.4 | -29.97 | -3.8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -0.67 | 0.52 | 0.21 | -2.88 | -6.95 | -32.84 | -3.98 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -0.67 | 0.54 | 0.25 | -2.65 | -6.51 | -31.06 | -3.77 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |